Cybin Inc. HELP
Annual
Quarterly
No annual revenue total was found in CYBIN INC.'s SEC filings.
Cybin Inc. (HELP) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
21.60M
-97.2% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HELP (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Toronto
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1833141
- Former names
- CYBIN INC. (until Sep 23, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 3, 2026 |
| 6-K | Current report (foreign issuer) | Oct 27, 2026 | Oct 27, 2026 |
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Oct 15, 2026 | Oct 15, 2026 |
| 6-K | Current report (foreign issuer) | Oct 8, 2026 | Oct 8, 2026 |
| 6-K | Current report (foreign issuer) | Oct 5, 2026 | Oct 1, 2026 |
All 452 Cybin Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.